Trend Results : Cancer Center


Blog Post Results (1-20 of 4250)

FILTER RESULTS

John Field, architect of Bay Area shopping centers, dies at 87

John Field, an architect and self-described “urban choreographer” who strove to humanize shopping centers in the Bay Area and elsewhere, died of cancer at his home in San Francisco on Feb. 21. Rather than reshape the skyline, Mr. Field...Show More Summary

Limiting Lung Cancer's Spread and Growth in the Brain

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

Jeffrey A. Drebin, MD, PhD, Named Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center

Jeffrey A. Drebin, MD, PhD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Drebin brings to MSK decades of experience as a world-class surgical oncologist specializing in pancreaticobiliary, upper gastrointestinal and liver surgery.

Bristol-Myers Squibb expands international immuno-oncology network (II-ON)

(Columbia University Medical Center) Bristol-Myers Squibb Company (NYSE:BMY) today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON).

Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre (Peter Mac) have joined the International Immuno-Oncology Network (II-ON).

Study finds biomarker for lung cancer detection in the nasal passages of smokers

(Boston University Medical Center) A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease. Researchers at Boston University School of Medicine (BUSM) have found that a genomic biomarker in the nasal passage can accurately determine the likelihood of a lung lesion being malignant.

Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson's Disease

Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson's disease.

Novel 'Barcode' Tracking of T Cells in Immunotherapy Patients Identifies Likely Cancer-Killers

A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer. The findings will be published February 24 in Science Immunology.

Novel 'barcode' tracking of T cells in immunotherapy patients identifies likely cancer-

(Fred Hutchinson Cancer Research Center) A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer.The findings will be published February 24 in Science Immunology.

Popstar created scholarship program for Caribbean students and built new center to fight breast cancer in Barbados

Today in Entertainment: Rihanna named Harvard Humanitarian of the Year; Sinéad O'Connor apologizes to Arsenio Hall for Prince comments Feb. 23, 2017, 9:55 a.m. With the Oscars around the corner and much of Hollywood still focused on the twists and turns of the presidency of Donald Trump, here's...

MD Anderson Cancer Center’s IBM Watson project fails, and so did the journalism related to it

We often call out overly optimistic news coverage of drugs and devices. But information technology is another healthcare arena where uncritical media narratives can cause harm by raising false hopes and allowing costly and unproven investments to proceed without scrutiny. A case in point is the recent collapse of M.D. Anderson Cancer Center’s ambitious venture […]

Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer

(University of Texas M. D. Anderson Cancer Center) Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.

University Hospitals Seidman Cancer Center Enrolls First Patient in New National Head and Neck Cancer Study

Story about the first patient enrolled in the new national phase I trial studying the side effects and best dose and schedule of pembrolizumab, an immunotherapy drug, when given together with chemotherapy and radiation therapy following surgery for very high risk head and neck cancer. Pembrolizumab is one of the first immunotherapy drugs.

Measuring patients' muscles to predict chemotherapy side effects

(UNC Lineberger Comprehensive Cancer Center) Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center report in the journal Clinical Cancer Research that measuring patients' muscle mass and quality could potentially help doctors better identify patients at high risk for toxic side effects that could require hospitalizations.

CAR T cells more powerful when built with CRISPR, MSK researchers find

(Memorial Sloan Kettering Cancer Center) Researchers from Memorial Sloan Kettering Cancer Center have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in m...

The Right Chemistry: Collaborating Across Multiple Disciplines

Researchers at The University of Kansas Cancer Center are collaborating on the "lab-on-a-chip," a testing platform that captures and performs analysis of various biomarkers, which are actively released by tumor cells into blood. Rather...Show More Summary

Mayo Clinic to host public cancer education symposium in Orlando

ORLANDO, Fla. — Mayo Clinic Cancer Center will host “Capture the Moment,” a free public cancer education symposium at the Ritz-Carlton at Orlando Grande Lakes, Florida, on March 25 from 7:30 a.m. to 6 p.m. EDT. This is the second consecutive year that Mayo Clinic Cancer Center has hosted this event in the Orlando area. […]

CNN Allows Left-Wing Guest to Accuse Trump of Creating 'Cancer of Anti-Semitism'

On CNN Tuesday afternoon, Steven Goldstein, director of the Anne Frank Center for Mutual Respect bashed lambasted President Donald Trump for his statement this morning denouncing bigotry, espcially anti-Semitism, and pinned recent Jew hatred on Trump's campaign, and now, administration. Show More Summary

Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peri

(University of Texas M. D. Anderson Cancer Center) For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

Gut bacteria associated with cancer immunotherapy response in melanoma

(University of Texas M. D. Anderson Cancer Center) Melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.

Copyright © 2015 Regator, LLC